Treatment of Plantar Warts

Comparative Study Between Topical30%Potassium Hydroxide Solution and Topical 45% Hydrogen Peroxide Solution in Treatment of Plantar Warts

Status

UNKNOWN

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05198180

Enrollment

Registered

2022-01-20

Start date

2022-02-28

Completion date

2022-12-31

Last updated

2022-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plantar Wart

Brief summary

This study is to compare the efficacy and safety of topical 30% potassium hydroxide solution and topical 45% hydrogen peroxide solution in treatment of plantar warts.

Interventions

DRUGTopical 30%Potassium hydroxide solution

Patients will apply the solution every day under occlusion for 3 months

DRUGTopical 45% hydrogen peroxide solution

Patients will apply the solution every day under occlusion

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

12 Years to No maximum

Healthy volunteers

Inclusion criteria

* confirmed diagnosis by clinical and dermoscopic examination of plantar warts

Exclusion criteria

* history of hypersensitivity to any component used in this study * pregnancy and breastfeeding * patients who receive immune suppressive therapy * patients who received any wart treatments during the last 2 months before enrollent in the study * patients who refused participation in the study

Design outcomes

Primary

Measure	Time frame	Description
Change in the size of the plantar warts	12 weeks after end of treatment	Decrease in the size of warts measured by a ruler

Countries

Egypt

Contacts

Primary ContactSamar Sa Ahmed, Resident

Summersayed156@gmail.com01152471005

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026